J.-P. Briand

4.8k citations

33 papers · 3.0k indexed · 3 hit papers · h-index 22

Impact in

Microbiology top 2%
- Antimicrobial Peptides and Activities
Immunology top 5%

Papers in

Virology 4
- HIV Research and Treatment 4
Immunology 11
- Immunotherapy and Immune Responses 3

Co-authors: Sylviane Muller Alberto Bianco Maurizio Prato M.H.V. Van Regenmortel Kostas Kostarelos Giorgia Pastorin Olivier Chaloin Ravi Singh
Journals: Journal of Biological Chemistry (3 papers)Journal of Immunological Methods (3 papers)Vaccine (2 papers)The Journal of Immunology (2 papers)Autophagy (1 paper)
Partner nations: France United Kingdom Netherlands

In The Last Decade

J.-P. Briand

33 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Functionalized Carbon Nanotubes Are Non-Cytotoxic and Preserve the Functionality of Primary Immune Cells 2006 · 541 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Nano Letters
2005 Journal of the American Chemical Society
1996 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by J.-P. Briand

Since Specialization

Citations

This map shows the geographic impact of J.-P. Briand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Briand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Briand more than expected).

Fields of papers citing papers by J.-P. Briand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. Briand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Briand. The network helps show where J.-P. Briand may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J.-P. Briand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J.-P. Briand Line = papers co-authored together J.-P. Briand links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis PLoS ONE ·Jürgen Dieker, Jo H. M. Berden, Marinka A.H. Bakker, J.-P. Briand, Sylviane Muller, Reinhard Voll, Christopher Sjöwall, Martin Herrmann, Luuk B. Hilbrands, Johan van der Vlag	2016	40
2	Modulation of deregulated chaperone-mediated autophagy by a phosphopeptide Autophagy ·Christophe Macri, Fengjuan Wang, Inmaculada Tasset, Nicolas Schall, Nicolas Pagé, J.-P. Briand, Ana María Cuervo, Sylviane Muller	2015	81
3	A novel receptor – ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu BMC Microbiology ·Monique Barel, Ara G. Hovanessian, Karin Lederballe Meibom, J.-P. Briand, Marion Dupuis, Alain Charbit	2008	79
4	Therapeutic peptides: Targeting the mitochondrion to modulate apoptosis Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Étienne Jacotot, Aurélien Deniaud, Annie Borgne‐Sanchez, Zahia Touat, J.-P. Briand, Morgane Le Bras, Catherine Brenner	2006	25
5	Double functionalisation of carbon nanotubes for multimodal drug delivery Chemical Communications ·Giorgia Pastorin, Wei Wu, Sébastien Wieckowski, J.-P. Briand, Kostas Kostarelos, Maurizio Prato, Alberto Bianco	2006	307
6	Functionalized Carbon Nanotubes Are Non-Cytotoxic and Preserve the Functionality of Primary Immune Cells Nano Letters ·A Den Dulk, Stéphanie Lacotte, Giorgia Pastorin, Riccardo Marega, Wei Wu, Davide Bonifazi, J.-P. Briand, Maurizio Prato, Sylviane Muller, Alberto Bianco Hit paper breakdown →	2006	541
7	tert-Butyl (6S)-4-hydroxy-6-isobutyl-2-oxo-1,2,5,6-tetrahydropyridine-1-carboxylate andtert-butyl (4R,6S)-4-hydroxy-6-isobutyl-2-oxopiperidine-1-carboxylate Acta Crystallographica Section C Crystal Structure Communications ·Claude Didierjean, 正健大橋, Emmanuel Wenger, J.-P. Briand, A. Aubry, Gilles Guichard	2004	1
8	Specificity and effect on apoptosis of Tat antibodies from vaccinated and SHIV-infected rhesus macaques and HIV-infected individuals Vaccine ·Joanne T. deKay, Anthony Romieu, Jean-François Zagury, Tomihara Takahiro, Olivier Chaloin, Roger Le Grand, Erwann Loret, J.-P. Briand, B P Roques, Claude Des̀granges, Sylviane Muller	2003	14
9	The Anti-HIV Cytokine Midkine Binds the Cell Surface-expressed Nucleolin as a Low Affinity Receptor Journal of Biological Chemistry ·Elias A. Said, Bernard Krust, Sébastien Nisole, Josette Svab, J.-P. Briand, Ara G. Hovanessian	2002	120
10	The HB-19 Pseudopeptide 5[Kpsi(CH ₂ N)PR]-TASP Inhibits Attachment of T Lymphocyte- and Macrophage-Tropic HIV to Permissive Cells AIDS Research and Human Retroviruses ·Sébastien Nisole, Bernard Krust, Erik B. Dam, Alberto Bianco, Nabila Seddiki, W. L. Xu, Christian Callebaut, Gilles Guichard, Sylviane Muller, J.-P. Briand, Ara G. Hovanessian	2000	25
11	The Anti-HIV Pseudopeptide HB-19 Forms a Complex with the Cell-surface-expressed Nucleolin Independent of Heparan Sulfate Proteoglycans Journal of Biological Chemistry ·Sébastien Nisole, Bernard Krust, Christian Callebaut, Gilles Guichard, Sylviane Muller, J.-P. Briand, Ara G. Hovanessian	1999	73
12	Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases Arthritis & Rheumatism ·Patrice Decker, J.-P. Briand, Gilbert de Murcia, Maria Camila Ceballos Santa, David Isenberg, Sylviane Muller	1998	29
13	Comparison of two different methods using overlapping synthetic peptides for localizing linear B cell epitopes in the U1 snRNP-C autoantigen Journal of Immunological Methods ·Tzu-Hsuan Lee, Hélène Dumortier, J.-P. Briand, Фирудин Мамедага Оглы Гасымов	1996	16
14	Selective induction of protection against influenza virus infection in mice by a lipid—peptide conjugate delivered in liposomes Vaccine ·Martin Friede, Sylviane Muller, J.-P. Briand, S. Plaué, Isabelle Fernandes, Benoı̂t Frisch, Francis Schuber, 真言森長	1994	24
15	Autoantibodies Reacting with Poly(ADP-Ribose) and with a Zinc-Finger Functional Domain of Poly(ADP-Ribose) Polymerase Involved in the Recognition of Damaged DNA Clinical Immunology and Immunopathology ·Sylviane Muller, J.-P. Briand, J. Gustova, Jean Lagueux, Guy G. Poirier, Gilbert de Murcia, David Isenberg	1994	36
16	Detection of potyviruses with antisera to synthetic peptides Research in Virology ·Hartman, Jude Kurankyi, J.-P. Briand, M.H.V. Van Regenmortel	1992	13
17	Application and limitations of the multiple antigen peptide (MAP) system in the production and evaluation of anti-peptide and anti-protein antibodies Journal of Immunological Methods ·J.-P. Briand, Leone de Camargo Setogute, Marc H.V. Van Regenmortel, Sylviane Muller	1992	71
18	A lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis The Journal of Immunology ·Nadine Tuaillon, Claire André, J.-P. Briand, Edward Penner, 村瀬智恵美	1992	47
19	Affinity purification of a rat‐brain junctional protein, connexin 43 European Journal of Biochemistry ·E. Dupont, Derici Yeşer Karaca, 香織永山, J.-P. Briand, Daniel Gros	1991	13
20	Synthetic peptides as antigens: Pitfalls of conjugation methods Journal of Immunological Methods ·J.-P. Briand, Sylviane Muller, M.H.V. Van Regenmortel	1985	252

About J.-P. Briand

J.-P. Briand is a scholar working on Virology, Immunology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Molecular Biology, having authored 33 papers that have together received 3.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), HIV Research and Treatment (4 papers), Bacteriophages and microbial interactions (4 papers), Glycosylation and Glycoproteins Research (3 papers), Carbon Nanotubes in Composites (3 papers), Immunotherapy and Immune Responses (3 papers), Plant Virus Research Studies (3 papers) and Transgenic Plants and Applications (3 papers). The work is most often cited by research in Microbiology (275 citations), Immunology (459 citations), Materials Chemistry (971 citations), Virology (99 citations) and Biomedical Engineering (867 citations). J.-P. Briand has collaborated with scholars based in France, United Kingdom and Netherlands. Frequent co-authors include Sylviane Muller, Alberto Bianco, Maurizio Prato, M.H.V. Van Regenmortel, Kostas Kostarelos, Giorgia Pastorin, Olivier Chaloin, Ravi Singh, Davide Pantarotto and David McCarthy. Their work appears in journals such as Journal of Biological Chemistry, Journal of Immunological Methods, Vaccine, The Journal of Immunology and Autophagy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact